Sign in
8-K

Current Report

Protalix BioTherapeutics, Inc. Filed Acc 0000950144-07-000141

Material agreement · Acquisition or sale completed · Unregistered share sale · Change in control · Executive or director change · Shell status change

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 3.02 Unregistered sales of equity securities
  • Item 5.01 Changes in control of the registrant
  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.06 Change in shell company status

From the SEC's structured data for this filing

Loading g04822e8vk.htm…